72
Participants
Start Date
December 23, 2022
Primary Completion Date
July 31, 2026
Study Completion Date
September 30, 2026
Denosumab
60 mg (1ml) administered subcutaneously once every 6 months for 12 months (totally 2 injections). Patients will also be supplemented with calcium carbonate (1000 mg/d) and cholecalciferol (800 IU/day), according to the recent guidelines.
Alendronate Sodium
70 mg (1 tablet) administered per os once weekly for 12 months. Patients will also be supplemented with calcium carbonate (1000 mg/d) and cholecalciferol (800 IU/day), according to the recent guidelines.
"Department of Endocrinology, Hippokration General Hospital of Thessaloniki", Thessaloniki
1st Department of Obstetrics and Gynecology, School, of Medicine, Aristotle University of Thessaloniki, Thessaloniki
424 General Military Hospital, Thessaloniki
424 General Military Hospital
OTHER
Aristotle University Of Thessaloniki
OTHER